Whether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).
Study finds no clinically useful biomarkers for long COVID in routine lab tests
- Post author:
- Post published:August 14, 2024
- Post category:uncategorized
Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.
Subscribe To Us
By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy
© 2024 Diabetes Prevention Awareness Center.